T1	Participants 125 184	'high risk' pre- and postmenopausal breast cancer patients.
T2	Participants 274 320	node positive breast cancer patients in Sweden
T3	Participants 410 447	e Stockholm Breast Cancer Study Group
T4	Participants 625 748	pre- (n = 547) and postmenopausal (n = 679) patients, respectively, with node positive disease or a tumour diameter > 30 mm
T5	Participants 912 934	premenopausal patients
